Infertility Services Market in US
Research analysts forecast the infertility services market in US to grow at a CAGR of 4.65% during the period 2017-2021.
Request sample copy of the report at: http://www.orbisresearch.com/contacts/request-sample/244699
Covered in this report
The report covers the present scenario and the growth prospects of the infertility services market in US for 2017-2021. To calculate the market size, the report considers the services carried out during treatment via infertility drugs and assisted reproductive technology (ART) services.
Research report, Infertility Services Market in US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Read more details of the report at: http://www.orbisresearch.com/reports/index/infertility-services-market-in-us-2017-2021
Other prominent vendors
OB GYN Associates
Reproductive Medicine Associates of New Jersey
The Sims Clinic
Xytex Cryo International
Rising success rate of infertility treatments.
For a full, detailed list, view our report
Limited reimbursements and lack of strict regulatory oversight.
For a full, detailed list, view our report
Upsurge in mergers and acquisitions.
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
CARE facility, CooperSurgical, Ferring Pharmaceuticals, Monash IVF, Merck, Vitrolife, AbbVie, Apricus Biosciences, AstraZeneca, Auxogyn, Eli Lilly, EMD Serono, IKS International, InVitro Care, INVO Bioscience, Irvine Scientific, LifeGlobal, MedITEX, NMC Health, OB GYN Associates, OvaScience, Pantec Biosolutions, Reproductive Medicine Associates of New Jersey, The Sims Clinic, TriHealth, Virtus Health, Xytex Cryo International.
Enquire more details of the report at: http://www.orbisresearch.com/contact/purchase/244699
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Infertility Services Market in US here
News-ID: 743721 • Views: 171
More Releases from Orbis Research
Cannabidiol (CBD) Cosmetics Market 2020 Segmentation, by Key Manufacturers: L'Or …
The CBD is a good antioxidant that can fight anxiety, pain, inflammation, epilepsy, reduce the proliferation of cancer cells, and prevent and prevent alzheimer’s disease and other beneficial effects. CBD cosmetics have the functions of whitening, anti-oxidation, anti-wrinkle, anti-aging, anti-inflammation, anti-acne, repairing deep basal cells and deeply cleaning skin. Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/3681281 The global Cannabidiol (CBD) Cosmetics market is valued at xx million US$ in 2018 and will reach xx
Factoring Market 2020 Segmentation, by Key Manufacturers: BNP Paribas, Deutsche …
The Factoring is a service of financial nature involving the conversion of credit bill into cash. It is a process or mechanism by which a company generates finance against its receivables. Factoring is asset-based financing in which the factor gives credit by looking at the creditworthiness of the borrower. Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/4418561 The research report studies the Factoring market using different methodologies and analyzes to provide accurate and in-depth information
Covid-19 Impact on Global E-cigarette and Vape Market Insights, Forecast to 2026
Vaping is the inhaling of a vapor created by an electronic cigarette (e-cigarette) or other vaping device. E-cigarettes are battery-powered smoking devices. They have cartridges filled with a liquid that usually contains nicotine, flavorings, and chemicals. The liquid is heated into a vapor, which the person inhales. That's why using e-cigarettes is called "vaping." Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/4655863 Growing concerns over the health risks associated with conventional tobacco
COVID-19 Impact on Global Licensed Merchandise Market Size, Status and Forecast …
In a merchandise license transaction, an artist, designer, trademark owner or celebrity (the "licensor") grants a license to a manufacturer or retailer (the "licensee") to manufacture and sell articles of merchandise which use the property that is the subject of the license, in exchange for a royalty from sales of those articles of merchandise. Typical licensed properties include artwork, characters, trademarks, celebrity names and likenesses, and book and movie titles.
More Releases for Infertility
Global Male Infertility Treatment Market Insights, Forecast
According to Word Health Organization, ‘Infertility is the inability of a sexually active, non-contraception couple to achieve pregnancy in one year’. About 15% of couples do not achieve pregnancy within 1year and seeking for infertility medical treatment. Less than 5% of world population is unwillingly childless. Approximately 90% of male infertility cases are seen mainly due to low sperm counts, and poor sperm quality. The remaining cases of male infertility
Women Infertility Market Pipeline Review, H2 2017
"The Report Women Infertility - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H2 2017, provides an overview of the Women Infertility (Women's Health) pipeline landscape. Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due
Global Infertility Drug Pipeline Analysis
The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques. The infertility drugs market promises significant room for growth. The market has high potential to scale up in order to meet the needs of infertile couples and also due to growth in reproductive tourism. Venture capitalists have entered the market by investing
Female Infertility-Pipeline Insights, 2017
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Female Infertility-Pipeline Insights, 2017 “Female Infertility-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Female Infertility. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III
Male Infertility - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Male Infertility - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Male Infertility – Pipeline Review, H1 2017, provides an overview of the Male Infertility (Male Health) pipeline landscape. Male infertility refers to a male's inability to achieve a pregnancy in a fertile female. Male infertility is
Infertility Services Market in US 2017-2021
Infertility is the failure to achieve pregnancy after 12 months of unprotected intercourse. Infertility occurs due to the abnormal functioning of the female and male reproductive system. It can be treated with infertility drugs and through procedures such as artificial insemination, in-vitro fertilization, and surrogacy. Technavios analysts forecast the infertility services market in US to grow at a CAGR of 4.65% during the period 2017-2021. Covered in this report The report covers the